Legislative solutions can incentivize research and development for lifesaving antimicrobials.
Emily Wheeler
Advertisement
Emily Wheeler is vice president of infectious disease policy at the Biotechnology Innovation Organization and director of Working to Fight AMR.
Articles by Emily Wheeler
Advertisement
Latest Updated Articles
Doctors — and patients — need new antibiotics. But a broken market can't deliver them.Published: August 25th 2025 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
Physicians taking back medicine: The rising toll of private equity in health care
2
If you give a kid a smartphone; kidney signal discovery points to new BP treatments; shingles vaccine could slow dementia – Morning Medical Update
3
ACIP and the hepatitis B vaccine: recommendations, mandates and patient informed consent
4
ACIP relies on evidence, transparency, critical reviews, vice chair says
5
